Comparing Brixadi vs Sublocade
| Brixadi (buprenorphine) | Sublocade (buprenorphine) |
|
|---|
| Brixadi (buprenorphine) | Sublocade (buprenorphine) |
|
|---|---|---|
|
Prescription only
Prescribed for Opiate Dependence - Maintenance, Opioid Use Disorder. Brixadi may also be used for purposes not listed in this medication guide. |
Prescription only
Sublocade is a once-monthly injection that may be used to treat adults with opioid use disorder and is administered subcutaneously (under the skin) into the stomach (abdomen), thigh, buttock, or... View more |
Related suggestions Opioid Use Disorder
Opiate Dependence - Maintenance
|
| More about Brixadi (buprenorphine) | More about Sublocade (buprenorphine) | |
| Ratings & Reviews | ||
|
Brixadi has an average rating of 6.0 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
Sublocade has an average rating of 7.9 out of 10 from a total of 307 ratings on Drugs.com. 72% of reviewers reported a positive effect, while 14% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
|
View all Brixadi side effects |
View all Sublocade side effects |
|
| Drug Class | ||
|
None |
None |
|
| Generic Availability | ||
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Other buprenorphine brands include: Belbuca, Buprenex, Butrans, Sublocade | Other buprenorphine brands include: Belbuca, Brixadi, Buprenex, Butrans | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
48 hours |
48 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
|
| Pregnancy Category | ||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 726 drugs are known to interact with Brixadi:
|
A total of 726 drugs are known to interact with Sublocade:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
|
|
| Disease Interactions | ||
| First Approval Date | ||
|
May 23, 2023 |
November 30, 2017 |
|
| WADA Class View classifications | ||
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.